Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Details Narrative)

Shareholders' Equity (Details Narrative)											3 Months Ended	12 Months Ended
Shareholders' Equity (Details Narrative)	Dec. 29, 2020 USD ($) $ / shares shares	Nov. 24, 2020 USD ($) $ / shares shares	May 14, 2020 shares	May 10, 2020 USD ($) Investors $ / shares shares	May 01, 2020 shares	May 10, 2019	May 01, 2019 $ / shares shares	Mar. 25, 2019 USD ($) $ / shares shares	Feb. 01, 2019 shares	Nov. 08, 2017 USD ($) Investors $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2019 shares	May 10, 2017 shares
Proceeds from public offering \| $								$ 12,500,000
Warrants outstanding												20,513,145
Proceeds from warrants \| $											$ 5,153,902
Preferred stock, shares authorized												50,000,000	50,000,000
Debt Conversion Agreement [Member] \| Precigen Note [Member]
Number of common stock issued in offering												100
Debt instrument aggregate amount including accrued interest \| $												$ 3,400,000
Series A Convertible Preferred Stock [Member]
Warrants exercise price per share \| $ / shares				$ 3.10
Warrants description				The warrants have a term of seven years from the date of issuance are non-exercisable until 6 months after issuance, have an exercise price of $3.10 per share.
Number of shares issued upon conversion, convertible preferred stock				258,300
Number of preferred stock converted				2,583,000
Series A Preferred Stock [Member]
Preferred stock, shares authorized														12,000,000
Series B Preferred Stock [Member]
Preferred stock, shares authorized														6,600,000
Series B Preferred Stock [Member] \| Debt Conversion Agreement [Member] \| Precigen Note [Member]
Number of shares issued upon conversion, value \| $												$ 2,400,000
Series C Preferred Stock [Member] \| Precigen Note [Member]
Number of common stock issued in offering												100
Series C Convertible Preferred Stock [Member]
Description on preferred stock, conversion basis												Upon any liquidation, dissolution or winding-up by us, whether voluntary or involuntary, the holders of Series C Preferred Stock shall be entitled to receive, in preference to the Junior Securities, an amount of cash equal to the product of (i) sum of (a) the number of shares of Series C Preferred Stock then held by such holder plus, (b) the number of shares of Series C Preferred Stock issuable to such holder in connection with any accrued but unpaid dividends, multiplied by (ii) the Stated Value, of $33,847.9874 per share, of Series C Preferred Stock ("the Series C Liquidation Amount") and no distribution or payments shall be made in respect of any Junior Securities unless all Series C Liquidation Amounts, if any, are first paid in full.
Preferred stock shares designated										1,000
Preferred stock dividend rate						20.00%						12.00%
2018 Warrants [Member]
Warrants exercise price per share \| $ / shares											$ 1.00
Warrants outstanding											760,000
Warrants acquired											4,294,500
2019 Warrants [Member]
Warrants exercise price per share \| $ / shares											$ 0.90
Warrants outstanding											4,882,114
Warrants acquired											9,583,334
First Closing [Member] \| Series A Convertible Preferred Stock [Member]
Warrants to purchase				462,106
Second Closing [Member] \| Series A Convertible Preferred Stock [Member]
Warrants to purchase				602,414
Noachis Terra Inc. [Member]
Number of common stock issued in offering					9,200,000
Three Accredited Investors [Member] \| Series A Convertible Preferred Stock [Member] \| Securities Purchase Agreement [Member]
Number of accredited investors \| Investors				3
Proceeds from convertible preferred stock \| $				$ 3,000,000
Description on preferred stock, conversion basis				The full $3,000,000 of Preferred Stock, and after giving effect to the reverse stock split and the previous conversion of 2,583,000 shares of Series A Preferred Stock into 258,300 shares of the Company's common stock, is convertible into nine hundred, forty-one thousand, seven hundred and one shares of our common stock, based on a fixed conversion price of $2.50 per share on an as-converted basis.
Common Stock [Member]
Number of common stock issued in offering								16,666,668			5,642,114		16,666,668
Issuance of stock as partial consideration for acquisition of certain services							12,500		12,500				25,000
Warrants description											Outstanding warrants as follows: (i) an additional 760,000 warrants of the Company's previously reported remaining outstanding warrants to acquire 4,294,500 shares of Common Stock at an exercise price of $1.00 per share issued in connection with its July 2018 public offering (the "2018 Warrants"), were exercised and (ii) 4,882,114 warrants of the Company's previously reported outstanding warrants to acquire 9,583,334 shares of Common Stock at an exercise price of $0.90 per share issued in connection with its March 2019 public offering (the "2019 Warrants"), were exercised (collectively the "Warrant Exercises").
Common Stock [Member] \| Maximum [Member]
Number of shares of stock available for purchase								2,500,000
Short Term Warrants [Member]
Warrants to purchase								8,333,334
Share price per unit \| $ / shares								$ 0.75
Long Term Warrants [Member]
Warrants to purchase								8,333,334
Share price per unit \| $ / shares								$ 0.75
Series 1 Warrant [Member] \| Dr. Frederick Telling [Member]
Warrants to purchase								50,000
Series 1 Warrant [Member] \| Dr. Alan Joslyn [Member]
Warrants to purchase								33,333
Series 2 Warrant [Member] \| Dr. Frederick Telling [Member]
Warrants to purchase								50,000
Series 2 Warrant [Member] \| Dr. Alan Joslyn [Member]
Warrants to purchase								33,333
Warrants [Member]
Stock issued during the period exercised			38,000
Short Term Warrants [Member]
Number of warrants available for purchase								1,250,000
Number of warrants purchased in period								1,250,000
Warrants exercise price per share \| $ / shares								$ 0.75
Long Term Warrants [Member]
Number of warrants available for purchase								1,250,000
Number of warrants purchased in period								1,250,000
Warrants exercise price per share \| $ / shares								$ 0.90
Warrants [Member] \| Noachis Terra Inc. [Member]
Number of common stock issued in offering					9,200,000
Warrants exercise price per share \| $ / shares							$ 1.25
Term of warrants							5 years
Underwritten Public Offering [Member]
Proceeds from public offering \| $								$ 12,500,000
Underwritten Public Offering [Member] \| Dr. Frederick Telling [Member]
Warrants to purchase								100,000
Underwritten Public Offering [Member] \| Dr. Alan Joslyn [Member]
Warrants to purchase								66,667
Underwritten Public Offering [Member] \| Common Stock [Member]
Number of common stock issued in offering								16,666,668
Underwritten Public Offering [Member] \| Short Term Warrants [Member]
Warrants to purchase								8,333,334
Share price per unit \| $ / shares								$ 0.75
Underwritten Public Offering [Member] \| Long Term Warrants [Member]
Warrants to purchase								8,333,334
Share price per unit \| $ / shares								$ 0.75
Underwriter [Member] \| Common Stock [Member] \| Maximum [Member]
Number of shares of stock available for purchase								2,500,000
Underwriter [Member] \| Short Term Warrants [Member]
Number of warrants available for purchase								1,250,000
Number of warrants purchased in period								1,250,000
Warrants exercise price per share \| $ / shares								$ 0.75
Exercisable term of warrants								18 months
Trading period								21 days
Underwriter [Member] \| Long Term Warrants [Member]
Number of warrants available for purchase								1,250,000
Number of warrants purchased in period								1,250,000
Warrants exercise price per share \| $ / shares								$ 0.90
Term of warrants								5 years
November 2020 Public Offering [Member]
Proceeds from public offering \| $		$ 6,000,000
November 2020 Public Offering [Member] \| Dr. Frederick Telling [Member]
Warrants to purchase		100,000
November 2020 Public Offering [Member] \| Common Stock [Member]
Number of common stock issued in offering		14,189,189
Share price per unit \| $ / shares		$ 0.37
Stock issued during the period exercised		2,128,378
November 2020 Public Offering [Member] \| Common Stock [Member] \| Maximum [Member]
Number of shares of stock available for purchase		2,128,378
December 2020 Registered Direct Offering [Member]
Proceeds from public offering \| $	$ 6,500,000
December 2020 Registered Direct Offering [Member] \| Common Stock [Member]
Number of common stock issued in offering	14,444,444
Share price per unit \| $ / shares	$ 0.45
Private Placement [Member] \| Series B Convertible Preferred Stock [Member]
Number of accredited investors \| Investors										4
Description on preferred stock, conversion basis										The full $3,300,000 of Series B Convertible Preferred Stock is convertible, after giving effect to the reverse stock split into one million three hundred and twenty thousand and two shares of our Common Stock, based on a conversion of one share of Series B Preferred Stock into two shares of Common Stock. The purchase price per share of the Series B Preferred Stock is represented by $2.50 per share of the Common Stock on an as converted basis.
Proceeds from issuance of private placement \| $										$ 3,300,000
Private Placement [Member] \| Warrants [Member] \| Series B Convertible Preferred Stock [Member]
Warrants to purchase										1,064,518
Warrants exercise price per share \| $ / shares										$ 3.10
Term of warrants										7 years